The Will Rogers phenomenon in the staging of breast cancer - does it matter?
Changes in the American Joint Commission on Cancer staging for breast cancer occurred when the 5th Edition was updated to the 6th Edition. To investigate how these changes affected stage and survival. 3127 cases of breast cancer were restaged. Late stages increased from 27.7% to 38.1%. The five-year survival improved in Stage 2 (82.9-86.1%) and Stage 3 (50.6-59%). Stage shift leads to an erroneous impression that women are presenting with later stages and stage-specific survival is improving. Standardizing cancer staging is important when reporting stage and survival in different time periods.